Skip to main content

Search form

Search

About the Department
Divisions
Faculty
- Distinguished Faculty
- Faculty Development
Patient Care
- Referrals
- In the Community
Research
Education and Training
MedicineNews

About the Department
Divisions
Faculty
- Distinguished Faculty
- Faculty Development
Patient Care
- Referrals
- In the Community
Research
Education and Training
MedicineNews

Home
Divisions
Hematologic Malignancies and Cellular Therapy
Research
Clinical Research

Hematologic Malignancies and Cellular Therapy

Clinical Research

Learn About Our Clinical Trials

BMT and Cellular Therapies
Leukemia and Multiple Myeloma
Lymphomas - Non-Hodgkins Lymphoma and Hodgkins Lymphoma

About
Faculty
Patient Care
Education and Training
Research
Division Events
Division News

Recent Articles

Duke Study Finds Expanded Cord Blood Shows Potential for Use in Adult Bone Marrow Transplants

Luftig named Fellow of the American Association for the Advancement of Science

Faculty promotions from January through June 2018

Divisions select faculty recipients for 2018 Excellence in Education Awards

Webb + LeBlanc present at Duke PC grand rounds

Recent publications by our faculty

Review of the patient-centered communication landscape in multiple myeloma and other hematologic malignancies.

Patient Educ Couns

Associations between Anxiety, Poor Prognosis, and Accurate Understanding of Scan Results among Advanced Cancer Patients.

Journal of Palliative Medicine

Ibrutinib plus fludarabine, cyclophosphamide, and rituximab as initial treatment for younger patients with chronic lymphocytic leukaemia: a single-arm, multicentre, phase 2 trial.

The Lancet Haematology

View all our publications

Quick Links

Diversity
Careers
Giving
About Duke and Durham

Twitter Instagram RSS

medschool.duke.edu
duke.edu
dukehealth.org

Copyright 2004-2018 Duke University and Duke University Health System, All rights reserved